FIELD: pharmacology.
SUBSTANCE: invention relates to laxative compositions, which contain: from about 2 to about 37 g of water-soluble sodium salt, water-soluble potassium salt; erythrite, xylose, xylotriose or their equivalents; bisoxatin (or 2,2-bis(4-hydroxyphenyl)-2H-benzo[b][1,4]oxazine-3(4H)-on) or bisoxatin acetate or its equivalent.
EFFECT: minimizing side effects.
35 cl, 4 ex
Authors
Dates
2018-01-12—Published
2012-10-27—Filed